Molecular Simulations of Aromatase Reveal New Insights Into the Mechanism of Ligand Binding-Reference-Cited by-同舟云学术

Molecular Simulations of Aromatase Reveal New Insights Into the Mechanism of Ligand Binding

Published:2013-08-09 Issue:8 Volume:53 Page:2047-2056
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Park Jiho¹,Czapla Luke¹,Amaro Rommie E.¹

Affiliation:

1. Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, 92093-0340, United States (Formerly located at: the Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California, 92697 United States)

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci400225w

Reference61 articles.

1. Molecular Characterization of Aromatase

2. ARIMIDEX™: A new oral, once-a-day aromatase inhibitor

3. Letrozole (CGS 20267), A New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

4. Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs;Journal of Inorganic Biochemistry;2023-10

2. Structures and functions of human placental aromatase and steroid sulfatase, two key enzymes in estrogen biosynthesis;Steroids;2023-08

3. A Theoretical Study of Organotin Binding in Aromatase;International Journal of Molecular Sciences;2023-05-18

4. Investigation of Novel Quinoline–Thiazole Derivatives as Antimicrobial Agents: In Vitro and In Silico Approaches;ACS Omega;2022-12-29

5. Design of novel quinoline derivatives as antibreast cancer using 3D-QSAR, molecular docking and pharmacokinetic investigation;Anti-Cancer Drugs;2022-09-14